21 Kim Wei He
Product Description
Sanofi
-
CN -
2016On CPHI since
Company types
Categories
Specifications
Sanofi
-
CN
-
2016On CPHI since
Company types
More Products from Sanofi (2)
-
Product Acebutolol hydrochloride
Sanofi offers a wide range of products which includes Acebutolol hydrochloride. THERAPEUTIC CLASS: Beta Blocking Agents. Contact us for more information. -
Product Acexamic acid
Sanofi offers a wide range of products which includes Acexamic acid. THERAPEUTIC CLASS: Dermatological Prd, Woundhealing Agents. Contact us for more information.
Sanofi resources (1)
-
News Sanofi gains rare disease therapy in acquisition of Inhibrx for US$1.7 billion
Sanofi completed the acquisition of the clinical-stage biotech company Inhibrx in late May 2024 after settling on a US$1.7 billion buyout. The acquisition brings with it a rare disease therapy to bollster Sanofi's pipeline.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance